The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

Following its spinoff from General Electric, GE HealthCare Technologies Inc. (NASDAQ:GEHC) has evolved from an established hardware developer into an AI-led, high-margin medtech player. The company ...

GE HealthCare Technologies has seen its share price slide this year, which naturally pushes investors to ask whether the ...

GE Healthcare will buy Sofie Biosciences in a $945 million cash deal, giving GE Healthcare U.S. access to a key imaging agent for PET scans.

SOFIE will continue serving its existing customers, including other radiopharmaceutical providers, following the deal. ・The transaction includes 15 CMO sites and 21 cyclotrons across SOFIE’s U.S.

GE HealthCare is positioned for a valuation re-rating. The SOFIE Biosciences acquisition enhances its precision medicine ...

The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...

Acquisition of Sofie Biosciences is second big purchase for medical imaging specialist after split from General Electric ...

Rodolphe Katra has joined from Medtronic to lead GE HealthCare’s efforts to connect devices, software and data.

The goal is to obtain last-mile logistics for radioactive agents with a short half-life that need to be made as close to patients as possible.

Add Yahoo as a preferred source to see more of our stories on Google. The solution will leverage predictive analytics and AI to recommend actions. Credit: raker / Shutterstock.com. GE HealthCare has ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash, expanding its U.S. PET radiopharmaceutical manufacturing and distribution network and strengthening its position in the ...